188 related articles for article (PubMed ID: 37436127)
21. The noncoding RNAs regulating pyroptosis in colon adenocarcinoma were derived from the construction of a ceRNA network and used to develop a prognostic model.
Chen Y; Tian Z; Hou H; Gai W
BMC Med Genomics; 2022 Sep; 15(1):201. PubMed ID: 36127676
[TBL] [Abstract][Full Text] [Related]
22. Peroxiredoxins and Immune Infiltrations in Colon Adenocarcinoma: Their Negative Correlations and Clinical Significances, an In Silico Analysis.
Zhang X; Gao F; Li N; Zhang J; Dai L; Yang H
J Cancer; 2020; 11(11):3124-3143. PubMed ID: 32231717
[No Abstract] [Full Text] [Related]
23. High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma.
Yang Y; Ye F; Xia T; Wang Q; Zhang Y; Du J
BMC Cancer; 2022 May; 22(1):487. PubMed ID: 35501725
[TBL] [Abstract][Full Text] [Related]
24. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma.
Hao YP; Wang WY; Qiao Q; Li G
Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884
[TBL] [Abstract][Full Text] [Related]
25. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
[TBL] [Abstract][Full Text] [Related]
26. Integration analysis of long non-coding RNA (lncRNA) role in tumorigenesis of colon adenocarcinoma.
Poursheikhani A; Abbaszadegan MR; Nokhandani N; Kerachian MA
BMC Med Genomics; 2020 Jul; 13(1):108. PubMed ID: 32727450
[TBL] [Abstract][Full Text] [Related]
27. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
Front Immunol; 2021; 12():665002. PubMed ID: 34367132
[TBL] [Abstract][Full Text] [Related]
28. SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma.
You W; Ke J; Chen Y; Cai Z; Huang ZP; Hu P; Wu X
Front Immunol; 2022; 13():864244. PubMed ID: 35720314
[TBL] [Abstract][Full Text] [Related]
29. Promoter hypermethylation and comprehensive regulation of ncRNA lead to the down-regulation of ZNF880, providing a new insight for the therapeutics and research of colorectal cancer.
Dong X; Zhang Y; Sun Y; Nan Q; Li M; Ma L; Zhang L; Luo J; Qi Y; Miao Y
BMC Med Genomics; 2023 Jun; 16(1):148. PubMed ID: 37370088
[TBL] [Abstract][Full Text] [Related]
30. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
31. CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma.
Meng C; Zhang Y; Jiang D; Wang J
World J Surg Oncol; 2022 Mar; 20(1):89. PubMed ID: 35307012
[TBL] [Abstract][Full Text] [Related]
32. ncRNAs-mediated TIMELESS overexpression in lung adenocarcinoma correlates with reduced tumor immune cell infiltration and poor prognosis.
Gao X; Tang M; Tian S; Li J; Wei S; Hua S; Liu W
PLoS One; 2024; 19(1):e0296829. PubMed ID: 38261568
[TBL] [Abstract][Full Text] [Related]
33. INSC Is Down-Regulated in Colon Cancer and Correlated to Immune Infiltration.
Yu T; Li D; Zeng Z; Xu X; Zhang H; Wu J; Song W; Zhu H
Front Genet; 2022; 13():821826. PubMed ID: 35664320
[No Abstract] [Full Text] [Related]
34. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
Jin L; Li C; Liu T; Wang L
Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
[TBL] [Abstract][Full Text] [Related]
35. Identification of fatty acid metabolism-related lncRNAs in the prognosis and immune microenvironment of colon adenocarcinoma.
Wu S; Gong Y; Chen J; Zhao X; Qing H; Dong Y; Li S; Li J; Wang Z
Biol Direct; 2022 Jul; 17(1):19. PubMed ID: 35902970
[TBL] [Abstract][Full Text] [Related]
36. Effects of SMC1A on immune microenvironment and cancer stem cells in colon adenocarcinoma.
Li J; Zhou Q; Liu L; He J
Cancer Med; 2023 Jun; 12(11):12881-12895. PubMed ID: 37096492
[TBL] [Abstract][Full Text] [Related]
37. A Competing Endogenous RNA Network Reveals Novel Potential lncRNA, miRNA, and mRNA Biomarkers in the Prognosis of Human Colon Adenocarcinoma.
Wang WJ; Li HT; Yu JP; Han XP; Xu ZP; Li YM; Jiao ZY; Liu HB
J Surg Res; 2019 Mar; 235():22-33. PubMed ID: 30691798
[TBL] [Abstract][Full Text] [Related]
38. Screening key long non-coding RNAs in early-stage colon adenocarcinoma by RNA-sequencing.
Liu JX; Li W; Li JT; Liu F; Zhou L
Epigenomics; 2018 Sep; 10(9):1215-1228. PubMed ID: 30182733
[TBL] [Abstract][Full Text] [Related]
39. Systematic analysis competing endogenous RNA coexpression network as a potentially prediction prognostic biomarker for colon adenocarcinoma.
Xi J; Zhang H; Li Y; Su H; Chen X; Liang X
Medicine (Baltimore); 2022 Sep; 101(39):e30681. PubMed ID: 36181111
[TBL] [Abstract][Full Text] [Related]
40. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.
Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y
Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
